These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 25259511)
1. Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico. Ballester V; Guo X; Vendrell R; Haritunians T; Klomhaus AM; Li D; McGovern DP; Rotter JI; Torres EA; Taylor KD PLoS One; 2014; 9(9):e108204. PubMed ID: 25259511 [TBL] [Abstract][Full Text] [Related]
2. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Roberts RL; Gearry RB; Hollis-Moffatt JE; Miller AL; Reid J; Abkevich V; Timms KM; Gutin A; Lanchbury JS; Merriman TR; Barclay ML; Kennedy MA Am J Gastroenterol; 2007 Dec; 102(12):2754-61. PubMed ID: 17894849 [TBL] [Abstract][Full Text] [Related]
4. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease. Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483 [TBL] [Abstract][Full Text] [Related]
5. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129 [TBL] [Abstract][Full Text] [Related]
6. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions. Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914 [TBL] [Abstract][Full Text] [Related]
7. Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Wang MH; Okazaki T; Kugathasan S; Cho JH; Isaacs KL; Lewis JD; Smoot DT; Valentine JF; Kader HA; Ford JG; Harris ML; Oliva-Hemker M; Cuffari C; Torbenson MS; Duerr RH; Silverberg MS; Rioux JD; Taylor KD; Nguyen GC; Wu Y; Datta LW; Hooker S; Dassopoulos T; Kittles RA; Kao LW; Brant SR Inflamm Bowel Dis; 2012 Dec; 18(12):2277-87. PubMed ID: 22411504 [TBL] [Abstract][Full Text] [Related]
8. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191 [TBL] [Abstract][Full Text] [Related]
9. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians. Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms present in IL10, IL23R, NOD2, and ATG16L1 associated with susceptibility to inflammatory bowel disease in Mexican population. Quiroz-Cruz S; Posada-Reyes B; Alatorre-García T; Del Real-Calzada CM; García-Samper X; Escobar-Gutiérrez A; Vázquez-Chacón CA; Martínez-Guarneros JA; Cruz-Rivera M; Vaughan G; Fonseca-Coronado S Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):10-16. PubMed ID: 31651650 [TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Brant SR; Okou DT; Simpson CL; Cutler DJ; Haritunians T; Bradfield JP; Chopra P; Prince J; Begum F; Kumar A; Huang C; Venkateswaran S; Datta LW; Wei Z; Thomas K; Herrinton LJ; Klapproth JA; Quiros AJ; Seminerio J; Liu Z; Alexander JS; Baldassano RN; Dudley-Brown S; Cross RK; Dassopoulos T; Denson LA; Dhere TA; Dryden GW; Hanson JS; Hou JK; Hussain SZ; Hyams JS; Isaacs KL; Kader H; Kappelman MD; Katz J; Kellermayer R; Kirschner BS; Kuemmerle JF; Kwon JH; Lazarev M; Li E; Mack D; Mannon P; Moulton DE; Newberry RD; Osuntokun BO; Patel AS; Saeed SA; Targan SR; Valentine JF; Wang MH; Zonca M; Rioux JD; Duerr RH; Silverberg MS; Cho JH; Hakonarson H; Zwick ME; McGovern DP; Kugathasan S Gastroenterology; 2017 Jan; 152(1):206-217.e2. PubMed ID: 27693347 [TBL] [Abstract][Full Text] [Related]
12. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. Latiano A; Palmieri O; Valvano MR; D'Incà R; Cucchiara S; Riegler G; Staiano AM; Ardizzone S; Accomando S; de Angelis GL; Corritore G; Bossa F; Annese V World J Gastroenterol; 2008 Aug; 14(29):4643-51. PubMed ID: 18698678 [TBL] [Abstract][Full Text] [Related]
14. Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort. Lv C; Yang X; Zhang Y; Zhao X; Chen Z; Long J; Zhang Y; Zhong C; Zhi J; Yao G; Jiang B; Zhi F Int J Colorectal Dis; 2012 Nov; 27(11):1465-72. PubMed ID: 22426692 [TBL] [Abstract][Full Text] [Related]
15. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease. Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Chrousos G; Anagnou NP; Roma-Giannikou E World J Gastroenterol; 2010 Apr; 16(14):1753-8. PubMed ID: 20380008 [TBL] [Abstract][Full Text] [Related]
16. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064 [TBL] [Abstract][Full Text] [Related]
17. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763 [TBL] [Abstract][Full Text] [Related]
18. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Cummings JR; Ahmad T; Geremia A; Beckly J; Cooney R; Hancock L; Pathan S; Guo C; Cardon LR; Jewell DP Inflamm Bowel Dis; 2007 Sep; 13(9):1063-8. PubMed ID: 17508420 [TBL] [Abstract][Full Text] [Related]